about
Genetic determinants and potential therapeutic targets for pancreatic adenocarcinomaThe BRCA1/2 pathway prevents hematologic cancers in addition to breast and ovarian cancersStructural determinants of the BRCA1 : estrogen receptor interactionStrategies for early detection of resectable pancreatic cancerRecent progress in pancreatic cancerReview of screening for pancreatic cancer in high risk individualsMultidisciplinary meeting on male breast cancer: summary and research recommendationsBRCA1 and BRCA2 as molecular targets for phytochemicals indole-3-carbinol and genistein in breast and prostate cancer cellsBRCA1 and BRCA2 pathways and the risk of cancers other than breast or ovarianAssociation of BRCA1 with the inactive X chromosome and XIST RNAMechanisms of inherited cancer susceptibilityDuctal approaches to assessment and management of women at high risk for developing breast cancerFounder mutations in BRCA1/2 are not frequent in Canadian Ashkenazi Jewish men with prostate cancerBRCA1/2 mutation screening and LOH analysis of lung adenocarcinoma tissue in a multiple-cancer patient with a strong family history of breast cancerGenetic variation in the HSD17B1 gene and risk of prostate cancer.High proportion of recurrent germline mutations in the BRCA1 gene in breast and ovarian cancer patients from the Prague areaThe importance of BRCA1 and BRCA2 genes mutations in breast cancer developmentPancreatic Cancer GeneticsGenetics and biology of pancreatic ductal adenocarcinomaScreening for pancreatic cancer in familial high-risk individuals: A systematic reviewDNA damage response and prostate cancer: defects, regulation and therapeutic implicationsEarly detection and prevention of pancreatic cancer: is it really possible today?Endoscopic ultrasonography for surveillance of individuals at high risk for pancreatic cancerEarly diagnosis of pancreatic cancer: challenges and new developmentsChallenging and complex decisions in the management of the BRCA mutation carrierChemoresistance and targeted therapies in ovarian and endometrial cancersGermline mutations in HOXB13 and prostate-cancer riskOverexpression of RAD51 occurs in aggressive prostatic cancerAssociations of high-grade prostate cancer with BRCA1 and BRCA2 founder mutationsBRCA1 and Oxidative StressGenome stability pathways in head and neck cancersPALB2, CHEK2 and ATM rare variants and cancer risk: data from COGSHuman variation databasesEndometrial cancer gene panels: clinical diagnostic vs research germline DNA testing.Screening for Pancreatic Cancer.High risk factors of pancreatic carcinoma.Clinical and molecular characterization of the BRCA2 p.Asn3124Ile variant reveals substantial evidence for pathogenic significance.BRCA1: a locus-specific "liaison" in gene expression and genetic integrity."Are you at risk for hereditary breast cancer?": development of a personal risk assessment tool for hereditary breast and ovarian cancer.Twenty questions in genetic medicine--an assessment of World Wide Web databases for genetics information at the point of care.
P2860
Q21129230-5263702E-6175-49FE-9CE5-EC3174839CC9Q21260410-F7CCDBFF-58B2-42B4-A546-210A64822C8EQ24292926-784E7D5D-308F-40C3-9BC0-E40F053BFE29Q24564006-31ED5137-2714-4903-A70E-AD4D0D9AE036Q24626346-1E9509BC-E45A-428A-8885-81D16076F6F7Q24630198-4CB18617-1716-48BD-97AE-E88D37F881E6Q24631800-D3C95BE2-8EF0-47F7-A0C4-69064CBCBBB9Q24652441-6D30F028-D75D-40A0-AA5B-B1EDC41553AFQ24672251-3777497B-1FE2-4282-A6C1-F778CDC442CCQ24675531-5DAF20F7-DA8A-4A4A-823B-08A37FE7E3D0Q24679752-DCA11369-F1DE-430A-A0E0-CA8DBA666869Q24794407-5CACB0EC-3A14-4C50-A128-C322D05EBA50Q24798248-C4EE17FE-0C12-471E-9F2C-0D1DC0EA3E71Q24805707-F0D1A1F7-48F1-44A3-9582-53AAEB03DDA3Q24811147-66847E34-82FB-4FD2-8917-BD0710C97453Q24813558-65196BDF-BA70-4ECD-A0C4-77432F66C8EEQ26738830-29993467-3221-4676-8A5B-1C8A48124BFCQ26765235-CFFEC2DD-B925-45DC-A6D2-C04CCB40EA10Q26765438-A7CB40EB-1AB9-4570-A0D7-0BF0FDC82F17Q26801172-C85D54BF-D797-4B6A-A425-245E61C8BA2BQ26829155-41B347DC-0BD9-434F-8607-022C281F99FAQ26865704-A21CB43A-6223-4D25-8E98-603E0AD6A252Q27010209-61B5A1DC-1BCE-40EE-BA7D-D764A5D38B2DQ27014027-6E055C97-66BB-4940-A60B-0B187A347E2AQ27026559-921F04F9-0B20-4BE3-A0FF-FA4C5B5CCE80Q28073246-1863C45D-0FF1-48F0-AC7A-EF42871D6A50Q28257179-9796AF46-D52A-47F9-8B3A-A76D4825D32CQ28267299-C13AFDA5-6ED2-4536-A49E-5D9E8F66755FQ28386233-243C24D4-1BF0-40F6-A09A-A46F62A6D3FBQ28388921-F74E13A9-C3B1-4542-B2B4-528EC8879315Q28391355-2CF5349B-F318-431B-9D8C-B0D8B0967BBAQ28584533-F6E8DEA9-9547-4AE7-8F5B-20F947256934Q28750141-07D1EBE2-A8A6-404F-8E9C-53D8FF432E1FQ30234614-281F3266-CED7-4D22-AC1F-86CE37875F46Q30240971-BF38A293-6C27-4ECA-8749-B6CB50D93261Q30249161-A720F8C2-283D-4BDC-8247-1DA03E3A3405Q30361333-EA8A925C-36EB-44EC-A631-0AE30498D2B8Q30436004-E686502C-CE46-4794-9B0E-8B06AFE3566CQ30445357-5233EB5E-868B-4588-A4D4-276147C52859Q30483973-9446660D-F323-4B66-9B1B-288485259F0E
P2860
description
2002 nî lūn-bûn
@nan
2002 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Cancer Incidence in BRCA1 mutation carriers.
@ast
Cancer Incidence in BRCA1 mutation carriers.
@en
Cancer Incidence in BRCA1 mutation carriers.
@nl
type
label
Cancer Incidence in BRCA1 mutation carriers.
@ast
Cancer Incidence in BRCA1 mutation carriers.
@en
Cancer Incidence in BRCA1 mutation carriers.
@nl
prefLabel
Cancer Incidence in BRCA1 mutation carriers.
@ast
Cancer Incidence in BRCA1 mutation carriers.
@en
Cancer Incidence in BRCA1 mutation carriers.
@nl
P356
P1476
Cancer Incidence in BRCA1 mutation carriers.
@en
P2093
Breast Cancer Linkage Consortium
Deborah Thompson
P304
P356
10.1093/JNCI/94.18.1358
P407
P577
2002-09-01T00:00:00Z